LAUSR

Abstract Inherited platelet disorders diagnosis is based on the clinical history and bleeding assessment tools. The laboratory functional assays as well as the molecular test to identify the pathogenic genetic variant are essential to confirm the accurate diagnosis of these disorders. Nowadays, the main challenges to developing a new diagnostic system are involved in reducing the samples’ volume, and faster and more helpful analysis. Moreover, there are no widely available and standardized global tests. High throughput genetic testing such as next-generation sequencing has revolutionized DNA sequencing technologies as it allows the simultaneous and faster investigation of multiple genes at a manageable cost. This technology has improved the molecular characterization of inherited platelet disorders and has been implemented in the research studies and the clinical routine practice.